1. Home
  2. AMCI vs LUNG Comparison

AMCI vs LUNG Comparison

Compare AMCI & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Robotics Corporation Common Stock

AMCI

AMC Robotics Corporation Common Stock

HOLD

Current Price

$3.25

Market Cap

110.5M

Sector

Finance

ML Signal

HOLD

Logo Pulmonx Corporation

LUNG

Pulmonx Corporation

HOLD

Current Price

$1.97

Market Cap

97.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCI
LUNG
Founded
2021
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Industrial Specialties
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.5M
97.1M
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
AMCI
LUNG
Price
$3.25
$1.97
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
★ $5.38
AVG Volume (30 Days)
98.2K
★ 283.1K
Earning Date
04-20-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 7.64
EPS
★ N/A
N/A
Revenue
$5,980,847.00
★ $90,497,000.00
Revenue This Year
N/A
$2.48
Revenue Next Year
N/A
$18.46
P/E Ratio
$476.00
★ N/A
Revenue Growth
N/A
★ 8.01
52 Week Low
$2.94
$1.13
52 Week High
$15.75
$2.89

Technical Indicators

Market Signals
Indicator
AMCI
LUNG
Relative Strength Index (RSI) 38.68 46.94
Support Level $3.01 $1.20
Resistance Level $3.99 $2.12
Average True Range (ATR) 0.27 0.11
MACD 0.04 -0.01
Stochastic Oscillator 33.77 56.53

Price Performance

Historical Comparison
AMCI
LUNG

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic and either do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.

Share on Social Networks: